Accuracy of rapid point-of-care antibody test in patients with suspected or confirmed COVID-19

Rama Vancheeswaran, Merlin Luke Willcox, Beth Stuart, Matthew Knight, Hala Kandil, Andrew Barlow, Mayon Haresh Patel, Jade Stockham, Aisling O'Neill, Tristan W Clark, Tom Wilkinson, Paul Little, Nick Francis, Gareth Griffiths, Michael Moore, Rama Vancheeswaran, Merlin Luke Willcox, Beth Stuart, Matthew Knight, Hala Kandil, Andrew Barlow, Mayon Haresh Patel, Jade Stockham, Aisling O'Neill, Tristan W Clark, Tom Wilkinson, Paul Little, Nick Francis, Gareth Griffiths, Michael Moore

No abstract available

Keywords: COVID-19; Lateral flow immunoassay; Point-of-care; Rapid antibody test; Sensitivity; Specificity.

Conflict of interest statement

Declaration of Competing Interest All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf . Prof Wilkinson reports grants, personal fees and other from AstraZeneca, grants and personal fees from Synairgen, grants and personal fees from MyMHealth, grants from GSK, grants from Bergenbio and grants from UC, outside the submitted work. Prof Griffiths reports grants from Jannsenn-Cilag, grants from AZ, grants from Novartis, grants from Astex, grants from Roche, grants from Heartflow, personal fees from Celldex, grants from BMS, grants from BionTech, outside the submitted work. All other authors declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Figures

Fig. 1

Flowchart for analysis compared to composite reference standard.